However, the capacity to trap PARP varies significantly among PARP inhibitors, with limited trapping activity estimated for veliparib: the PARP trapping IC50 at 57.4 umol/L50 is far above the tumor concentrations measured in our study. Here, PARP1 is linked to neoplasm.